Macrolides
    11.
    发明授权
    Macrolides 失效
    大环内酯类

    公开(公告)号:US06518251B1

    公开(公告)日:2003-02-11

    申请号:US09715394

    申请日:2000-11-17

    IPC分类号: A61K3170

    CPC分类号: C07H17/08 C07H17/00

    摘要: The invention relates to compounds of Formula 1 and to pharmaceutically acceptable salts, solvates, and prodrugs thereof, wherein X, Y, Z, R1, R2, R3, R4, and R5 are defined herein. The invention further relates to methods of making compounds of Formula 1 and to pharmaceutical compositions comprising compounds of Formula 1. The invention is also related to methods of treating diseases and disorders such as, but not limited to, bacterial and protozoal infections which comprise the administration of a compound of Formula 1, or a pharmaceutically acceptable salt, solvate, or prodrug thereof.

    摘要翻译: 本发明涉及式1的化合物及其药学上可接受的盐,溶剂合物和前药,其中X,Y,Z,R 1,R 2,R 3,R 4和R 5在本文中定义。 本发明还涉及制备式1化合物的方法和包含式1化合物的药物组合物。本发明还涉及治疗疾病和病症的方法,例如但不限于包含给药的细菌和原生动物感染 的式1的化合物或其药学上可接受的盐,溶剂合物或前药。

    C11 carbamates of macrolide antibacterials
    12.
    发明授权
    C11 carbamates of macrolide antibacterials 失效
    C11大环内酯类抗生素的氨基甲酸酯

    公开(公告)号:US6043227A

    公开(公告)日:2000-03-28

    申请号:US320352

    申请日:1999-05-26

    IPC分类号: C07H17/08 A61K31/70

    CPC分类号: C07H17/08 Y02P20/55

    摘要: This invention relates to compounds of the formula ##STR1## and to pharmaceutically acceptable salts thereof. The compounds of formula 1 are potent antibacterial agents that may be used to treat various bacterial infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating bacterial infections by administering the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1 and to intermediates useful in such preparation.

    摘要翻译: 本发明涉及式的化合物及其药学上可接受的盐。 式1的化合物是可用于治疗各种细菌感染和与这种感染有关的疾病的有效的抗菌剂。 本发明还涉及含有式1化合物的药物组合物和通过施用式1化合物治疗细菌感染的方法。本发明还涉及制备式1化合物的方法和用于此类制备的中间体。

    3,6-ketal and enol ether macrolide antibiotics
    13.
    发明授权
    3,6-ketal and enol ether macrolide antibiotics 失效
    3,6-缩酮和烯醇醚大环内酯类抗生素

    公开(公告)号:US6043226A

    公开(公告)日:2000-03-28

    申请号:US257709

    申请日:1999-02-25

    CPC分类号: C07H17/08

    摘要: This invention relates to compounds of formulas 1 and 2 ##STR1## and to pharmaceutically acceptable salts and solvates thereof, wherein X, X.sup.1, R.sup.1, R.sup.2, R.sup.7, R.sup.17 and R.sup.19 are as defined herein. The compounds of formulas 1 and 2 may be useful in the treatment of bacterial, parasitic and protozoal infections, as well as disorders related to bacterial, parasitic and protozoal infections, in mammals, fish and birds. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and 2 and to methods of treating bacterial, parasitic and protozoal infections by administering the compounds of formula 1 and 2.

    摘要翻译: 本发明涉及式1和式2的化合物及其药学上可接受的盐和溶剂合物,其中X,X 1,R 1,R 2,R 7,R 17和R 19如本文所定义。 式1和2的化合物可用于治疗细菌,寄生虫和原生动物感染以及与哺乳动物,鱼和鸟类中的细菌,寄生虫和原生动物感染有关的疾病。 本发明还涉及含有式1和2化合物的药物组合物以及通过施用式1和式2化合物来治疗细菌,寄生虫和原生动物感染的方法。

    Methods of making macrolides
    18.
    发明授权
    Methods of making macrolides 失效
    制备大环内酯类的方法

    公开(公告)号:US06727352B2

    公开(公告)日:2004-04-27

    申请号:US10226760

    申请日:2002-08-23

    IPC分类号: C07H100

    CPC分类号: C07H17/08 C07H17/00

    摘要: This invention relates to methods of preparing a compound of Formulae 2, 5 and 7, wherein R2-R5, R7, R9, R10 and R15 are defined herein.

    摘要翻译: 本发明涉及制备式2,5和7化合物的方法,其中R 2 -R 5,R 7,R 9,R 10和R 15如本文所定义 。